跳至主要内容
临床试验/NCT03047070
NCT03047070已完成2 期

Lidocaine Infusion in Functional Endoscopic Sinus Surgery

Assiut University2 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2017年2月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
43
试验地点
2
主要终点
Intraoperative bleeding

研究概览

简要总结

Functional endoscopic sinus surgery (FESS) is a commonly performed procedure. It is known that bleeding during FESS can affect directly to the visibility of safe landmarks and surgical outcomes.

详细描述

Functional endoscopic sinus surgery (FESS) is a commonly performed procedure in the head and neck field. It is known that bleeding during FESS can affect directly to the visibility of safe landmarks and surgical outcomes.

Use of vasoactive drugs to control bleeding is not without pitfalls. Systemic effects of epinephrine may constitute a potential hazard in patients with hypertension, ischemic heart disease, anemia, preexistent liver or renal damage and endocrine dysfunction (hyperthyroidism, pheochromocytoma and diabetes mellitus).

Lidocaine is a prototypical local anesthetic, but it also has systemic effects that are mediated by inhibitory effects on N-methyl-d-aspartate receptors and leukocyte priming. Consequently, systemic lidocaine is antiinflammatory, analgesic, and antihyperalgesic. Randomized clinical trials, however, have produced mixed results. Several studies have shown reduction in postoperative opioid consumption and pain scores, whereas others have failed to show a benefit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients, 20-50 yr ASA class I and II
  • Elective Functional endoscopic sinus surgery (FESS) under general anesthesia.

排除标准

  • Patient refusal, allergy to the study medication, pre-existing chronic pain at any site requiring treatment, intolerance to nonsteroidal anti-inflammatory drugs (NSAIDs), psychiatric or neurological disorders, seizure disorder requiring medication within the previous 2 years, body mass index > 30 kg/ m2, revision sinus surgery, pregnancy, and patients with cardiovascular, cerebrovascular, respiratory, renal or hepatic diseases

研究组 & 干预措施

Lidocaine

Active Comparator

IV Lidocaine infusion

干预措施: Lidocaine (Drug)

Control

Placebo Comparator

IV normal saline infusion

干预措施: Normal saline (Drug)

结局指标

主要结局

Intraoperative bleeding

时间窗: Intraoperative assessment till end of operation

Will be calculated from the fluid volume of the suction canister. The volume of irrigating fluid will subtracted from the total volume of fluid contained in the suction bottle. Additionally, a fully soaked cotton strip will be assumed to contain 5 ml of blood and a partially soaked one to contain 2-3 ml of blood

次要结局

  • Surgeon satisfaction(At the end of surgery)
  • Heart rate(intraoperative assessment)
  • Mean arterial pressure(intraoperative assessment)
  • Quality of surgical field(intraoperative assessment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seham Mohamed Moeen Ibrahim

lecturer

Assiut University

研究点 (2)

Loading locations...

相似试验